Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Recep Emre Okyay, Buket Çetintaş, Aslı Akdöner, İbrahim Öztura, Gaye Eryaşar Yildirim, Erkan Çağliyan, Onur Yavuz & Ali Rıza Şişman. (2022) The effect of oral contraceptive use on sympatic nerve activity in patients with polycystic ovary syndrome. Gynecological Endocrinology 38:7, pages 592-597.
Read now
Read now
Mariano Bizzarri, Patrizia Logoteta, Giovanni Monastra & Antonio Simone Laganà. (2022) An innovative approach to polycystic ovary syndrome. Journal of Obstetrics and Gynaecology 42:4, pages 546-556.
Read now
Read now
Fabio Facchinetti, Marialuisa Appetecchia, Cesare Aragona, Arturo Bevilacqua, Maria Salome Bezerra Espinola, Mariano Bizzarri, Rosario D’Anna, Didier Dewailly, Evanthia Diamanti-Kandarakis, Imelda Hernández Marín, Zdravko A. Kamenov, Eleni Kandaraki, Antonio Simone Laganà, Giovanni Monastra, Mario Montanino Oliva, John E. Nestler, Francesco Orio, Ali Cenk Ozay, Olga Papalou, Lali Pkhaladze, Giusy Porcaro, Nikos Prapas, Christophe O. Soulage, Annarita Stringaro, Artur Wdowiak & Vittorio Unfer. (2020) Experts’ opinion on inositols in treating polycystic ovary syndrome and non-insulin dependent diabetes mellitus: a further help for human reproduction and beyond. Expert Opinion on Drug Metabolism & Toxicology 16:3, pages 255-274.
Read now
Read now
Kamal Advani, Madhulika Batra, Sangeeta Tajpuriya, Rajani Gupta, Alka Saraswat, Hemant D. Nagar, Laljee Makwana, Sarika Kshirsagar, Pushpa Kaul, Asim Kumar Ghosh, Sandhya Pradhan, Ami Mehta, Anil Jaiswal, Kartik T. Nakhate & Sandesh Kamdi. (2020) Efficacy of combination therapy of inositols, antioxidants and vitamins in obese and non-obese women with polycystic ovary syndrome: an observational study. Journal of Obstetrics and Gynaecology 40:1, pages 96-101.
Read now
Read now
Maryam Shokrpour, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Zahra Vahedpoor, Esmat Aghadavod, Amir Ghaderi & Zatollah Asemi. (2019) Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial. Gynecological Endocrinology 35:5, pages 406-411.
Read now
Read now
Magda Lambaa Altinok, Pernille Ravn, Marianne Andersen & Dorte Glintborg. (2018) Effect of 12-month treatment with metformin and/or oral contraceptives on health-related quality of life in polycystic ovary syndrome. Gynecological Endocrinology 34:10, pages 859-863.
Read now
Read now
Antoaneta Gateva, Vittorio Unfer & Zdravko Kamenov. (2018) The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review. Gynecological Endocrinology 34:7, pages 545-550.
Read now
Read now
Paolo Giovanni Artini, Maria Elena Rosa Obino, Claudia Sergiampietri, Sara Pinelli, Francesca Papini, Elena Casarosa & Vito Cela. (2018) PCOS and pregnancy: a review of available therapies to improve the outcome of pregnancy in women with polycystic ovary syndrome. Expert Review of Endocrinology & Metabolism 13:2, pages 87-98.
Read now
Read now
Giovanni Monastra, Vittorio Unfer, Abdel Halim Harrath & Mariano Bizzarri. (2017) Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients. Gynecological Endocrinology 33:1, pages 1-9.
Read now
Read now
Cristiana Paul, Antonio Simone Laganà, Paolo Maniglio, Onofrio Triolo & David M. Brady. (2016) Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives. Gynecological Endocrinology 32:6, pages 431-438.
Read now
Read now
Alessandro Pacchiarotti, Gianfranco Carlomagno, Gabriele Antonini & Arianna Pacchiarotti. (2016) Effect of myo-inositol and melatonin versus myo-inositol, in a randomized controlled trial, for improving in vitro fertilization of patients with polycystic ovarian syndrome. Gynecological Endocrinology 32:1, pages 69-73.
Read now
Read now
Arturo Bevilacqua, Gianfranco Carlomagno, Sandro Gerli, Mario Montanino Oliva, Paul Devroey, Antonio Lanzone, Christophe Soulange, Fabio Facchinetti, Gian Carlo Di Renzo, Mariano Bizzarri, Moshe Hod, Pietro Cavalli, Rosario D’Anna, Salvatore Benvenga, Tony T. Chiu & Zdravko A. Kamenov. (2015) Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology – assisted reproduction technology. Gynecological Endocrinology 31:6, pages 441-446.
Read now
Read now
Zdravko Kamenov, Georgi Kolarov, Antoaneta Gateva, Gianfranco Carlomagno & Alessandro D. Genazzani. (2015) Ovulation induction with myo-inositol alone and in combination with clomiphene citrate in polycystic ovarian syndrome patients with insulin resistance. Gynecological Endocrinology 31:2, pages 131-135.
Read now
Read now
Nicolas Mendoza, Tommaso Simoncini & Alessandro D. Genazzani. (2014) Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies. Gynecological Endocrinology 30:12, pages 850-860.
Read now
Read now
Vittorio Unfer & Giuseppina Porcaro. (2014) Updates on the myo-inositol plus D-chiro-inositol combined therapy in polycystic ovary syndrome. Expert Review of Clinical Pharmacology 7:5, pages 623-631.
Read now
Read now
Articles from other publishers (29)
Gabriela Batóg, Anna Dołoto, Ewelina Bąk, Iwona Piątkowska-Chmiel, Paulina Krawiec, Elżbieta Pac-Kożuchowska & Mariola Herbet. (2023) The interplay of oxidative stress and immune dysfunction in Hashimoto’s thyroiditis and polycystic ovary syndrome: a comprehensive review. Frontiers in Immunology 14.
Crossref
Crossref
Zdravko Kamenov & Mario Montanino Oliva. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
65
72
.
Lali Pkhaladze, Vittorio Unfer & Didier Dewailly. 2023. A Clinical Guide to Inositols. A Clinical Guide to Inositols
151
165
.
Ling-Hui Zeng, Saba Rana, Liaqat Hussain, Muhammad Asif, Malik Hassan Mehmood, Imran Imran, Anam Younas, Amina Mahdy, Fakhria A. Al-Joufi & Shaymaa Najm Abed. (2022) Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies. Frontiers in Pharmacology 13.
Crossref
Crossref
Meysam Zarezadeh, Azadeh Dehghani, Amir Hossein Faghfouri, Nima Radkhah, Mohammad Naemi Kermanshahi, Fatemeh Hamedi Kalajahi, Niyaz Mohammadzadeh Honarvar, Zohreh Ghoreishi, Alireza Ostadrahimi & Mehrangiz Ebrahimi Mamaghani. (2021) Inositol supplementation and body mass index: A systematic review and meta‐analysis of randomized clinical trials. Obesity Science & Practice 8:3, pages 387-397.
Crossref
Crossref
Rumaisa Rashid, Suhail Ahmad Mir, Ozaifa Kareem, Tabassum Ali, Rifat Ara, Anjum Malik, Fiza Amin & G.N. Bader. (2022) Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. Taiwanese Journal of Obstetrics and Gynecology 61:1, pages 40-50.
Crossref
Crossref
Athanasios Antoniou-Tsigkos, Konstantina Pastroma, Eleni Memi, Nikolaos Vrachnis & George Mastorakos. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
135
152
.
Georgios K. Markantes, Gina Tsichlia & Neoklis A. Georgopoulos. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome
97
115
.
Ol'ga S. Alyautdina, Viktoriya Y. Prilutskaya & Ekaterina I. Krylova. (2021) The use of inositol stereoisomers for the treatment of patients with clinical and biochemical signs of hyperandrogenism. V.F.Snegirev Archives of Obstetrics and Gynecology 8:2.
Crossref
Crossref
Li-Yan Jia, Jia-Xing Feng, Juan-Li Li, Fang-Yuan Liu, Liang-zhen Xie, Shou-Juan Luo & Feng-Juan Han. (2021) The Complementary and Alternative Medicine for Polycystic Ovary Syndrome: A Review of Clinical Application and Mechanism. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-12.
Crossref
Crossref
Zdravko Kamenov & Antoaneta Gateva. (2020) Inositols in PCOS. Molecules 25:23, pages 5566.
Crossref
Crossref
M. Caputo, E. Bona, I. Leone, M.T. Samà, A. Nuzzo, A. Ferrero, G. Aimaretti, P. Marzullo & F. Prodam. (2020) Inositols and metabolic disorders: From farm to bedside. Journal of Traditional and Complementary Medicine 10:3, pages 252-259.
Crossref
Crossref
Anna Wojciechowska, Adam Osowski, Marcin Jóźwik, Ryszard Górecki, Andrzej Rynkiewicz & Joanna Wojtkiewicz. (2019) Inositols’ Importance in the Improvement of the Endocrine–Metabolic Profile in PCOS. International Journal of Molecular Sciences 20:22, pages 5787.
Crossref
Crossref
Reza Tabrizi, Vahidreza Ostadmohammadi, Kamran B. Lankarani, Payam Peymani, Maryam Akbari, Fariba Kolahdooz & Zatollah Asemi. (2018) The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Lipids in Health and Disease 17:1.
Crossref
Crossref
Manuel Luque-Ramírez, Lía Nattero-Chávez, Andrés E Ortiz Flores & Héctor F Escobar-Morreale. (2018) Combined oral contraceptives and/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update 24:2, pages 225-241.
Crossref
Crossref
Sebastião Freitas de Medeiros. (2017) Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome. Reproductive Biology and Endocrinology 15:1.
Crossref
Crossref
R Hanna, T Wehbe & EA Jaoude. (2017) Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome. International Journal of Clinical Endocrinology and Metabolism 3:1, pages 029-033.
Crossref
Crossref
Mehri Jamilian, Pegah Farhat, Fatemeh Foroozanfard, Faraneh Afshar Ebrahimi, Esmat Aghadavod, Fereshteh Bahmani, Bita Badehnoosh, Hamidreza Jamilian & Zatollah Asemi. (2017)
Expression of Concern
: Comparison of myo‐inositol and metformin on clinical, metabolic and genetic parameters in polycystic ovary syndrome: A randomized controlled clinical trial
. Clinical Endocrinology 87:2, pages 194-200.
Crossref
Crossref
Maria A. Sortino, Salvatore Salomone, Michele O. Carruba & Filippo Drago. (2017) Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols. Frontiers in Pharmacology 8.
Crossref
Crossref
G. Simi, A. R. Genazzani, M. E. R. Obino, F. Papini, S. Pinelli, V. Cela & P. G. Artini. (2017) Inositol and In Vitro Fertilization with Embryo Transfer. International Journal of Endocrinology 2017, pages 1-5.
Crossref
Crossref
Saghar Salehpour, Leila Nazari, Sedighe Hoseini, Nasrin Saharkhiz, Fatemeh Ghazi & Mohammad Reza Sohrabi. (2016) A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Ali Cenk Ozay, Ozlen Emekci Ozay, Recep Emre Okyay, Erkan Cagliyan, Tuncay Kume & Bulent Gulekli. (2016) Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women. International Journal of Endocrinology 2016, pages 1-8.
Crossref
Crossref
Elena Benelli, Scilla Del Ghianda, Caterina Di Cosmo & Massimo Tonacchera. (2016) A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women. International Journal of Endocrinology 2016, pages 1-5.
Crossref
Crossref
Deepika Garg & Reshef Tal. (2016) Inositol Treatment and ART Outcomes in Women with PCOS. International Journal of Endocrinology 2016, pages 1-9.
Crossref
Crossref
Lali Pkhaladze, Ludmila Barbakadze & Nana Kvashilava. (2016) Myo-Inositol in the Treatment of Teenagers Affected by PCOS. International Journal of Endocrinology 2016, pages 1-6.
Crossref
Crossref
Simona Dinicola, Tony T. Y. Chiu, Vittorio Unfer, Gianfranco Carlomagno & Mariano Bizzarri. (2014) The rationale of the myo-inositol and D-chiro-inositol combined treatment for polycystic ovary syndrome. The Journal of Clinical Pharmacology 54:10, pages 1079-1092.
Crossref
Crossref
Shahnaz TorkzahraniAfrooz HeidariZohreh Mostafavi-pourMajid AhmadiFatemeh Zal. (2014) Amelioration of lipid abnormalities by vitamin therapy in women using oral contraceptives. Clinical and Experimental Reproductive Medicine 41:1, pages 15.
Crossref
Crossref
S. O. Dubrovina. (2014) Polycystic ovary syndrome: the strategy of diagnosis and treatment. Problemy reproduktsii:6, pages 10.
Crossref
Crossref
Sandra Colazingari, Mariangela Treglia, Robert Najjar & Arturo Bevilacqua. (2013) The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics 288:6, pages 1405-1411.
Crossref
Crossref